Literature DB >> 8295175

Levels of urinary polyamines in patients with rheumatoid arthritis.

Y Furumitsu1, K Yukioka, A Kojima, M Yukioka, K Shichikawa, T Ochi, I Matsui-Yuasa, S Otani, Y Nishizawa, H Morii.   

Abstract

OBJECTIVE: To compare urinary polyamine levels in patients with rheumatoid arthritis (RA), with osteoarthritis (OA), and in healthy controls and examine the relationship between urinary polyamine levels and several disease variables in patients with RA.
METHODS: We determined the concentrations of urinary polyamines in 33 patients with RA, 24 with OA, and 20 healthy controls, using the enzymatic assay method. For patients with RA relevant clinical and laboratory variables were obtained and functional and radiologic scores determined for the joints.
RESULTS: Urinary polyamine levels were significantly higher in patients with RA versus those with OA and healthy controls. In patients with RA the levels of urinary polyamines correlated significantly with the concentrations of serum C-reactive protein (CRP); there was also a statistically significant negative correlation between their urinary polyamine levels and average grip strength in either hand. Moreover, the levels of urinary polyamines in patients with RA showed an increase in proportion to the degree of joint functional damage and radiologic progression.
CONCLUSION: Our results confirm our previous report of an increase in the amount of free putrescine in synovial fluids and a significant correlation between the putrescine contents of synovial tissues and the serum CRP concentrations in patients with RA; they also suggest that urinary polyamine levels may be related to the activity and progression of RA, indicating that polyamine may play an important role in RA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8295175

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Epigenetics in the pathogenesis of RA.

Authors:  Caroline Ospelt; Steffen Gay; Kerstin Klein
Journal:  Semin Immunopathol       Date:  2017-03-21       Impact factor: 9.623

Review 2.  Autoimmune diseases and polyamines.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

3.  Polyamine depletion inhibits NF-kappaB binding to DNA and interleukin-8 production in human chondrocytes stimulated by tumor necrosis factor-alpha.

Authors:  Annalisa Facchini; Rosa Maria Borzí; Kenneth B Marcu; Claudio Stefanelli; Eleonora Olivotto; Mary B Goldring; Andrea Facchini; Flavio Flamigni
Journal:  J Cell Physiol       Date:  2005-09       Impact factor: 6.384

Review 4.  Methotrexate and its mechanisms of action in inflammatory arthritis.

Authors:  Bruce N Cronstein; Thomas M Aune
Journal:  Nat Rev Rheumatol       Date:  2020-02-17       Impact factor: 20.543

5.  Adenosine in inflammatory joint diseases.

Authors:  E S L Chan; P Fernandez; B N Cronstein
Journal:  Purinergic Signal       Date:  2007-01-03       Impact factor: 3.765

6.  Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages.

Authors:  Kyung-Ran Park; Chul Ju Hwang; Hyung-Mun Yun; In Jun Yeo; Dong-Young Choi; Pil-Hoon Park; Hyung Sook Kim; Jung Tae Lee; Young Suk Jung; Sang-Bae Han; Jin Tae Hong
Journal:  Stem Cell Res Ther       Date:  2020-03-04       Impact factor: 6.832

Review 7.  An Epigenetics-Based Hypothesis of Autoantigen Development in Systemic Lupus Erythematosus.

Authors:  Wesley Brooks
Journal:  Epigenomes       Date:  2020-04-23

8.  Inhibiting peripheral and central MAO-B ameliorates joint inflammation and cognitive impairment in rheumatoid arthritis.

Authors:  Woojin Won; Hyun-Ji Choi; Ji-Young Yoo; Daeun Kim; Tai Young Kim; YeonHa Ju; Ki Duk Park; Hyunbeom Lee; Sang Youn Jung; C Justin Lee
Journal:  Exp Mol Med       Date:  2022-08-18       Impact factor: 12.153

Review 9.  Molecular action of methotrexate in inflammatory diseases.

Authors:  Edwin S L Chan; Bruce N Cronstein
Journal:  Arthritis Res       Date:  2002-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.